---
title: A BCT Intervention for an Hourly Activity Habit Among Caregivers for Persons With AD/ADRD
nct_id: NCT06801912
overall_status: ACTIVE_NOT_RECRUITING
phase: NA
sponsor: Northwell Health
study_type: INTERVENTIONAL
primary_condition: Sedentary Behavior
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT06801912.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06801912"
ct_last_update_post_date: 2026-02-27
last_seen_at: "2026-05-12T06:29:33.185Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# A BCT Intervention for an Hourly Activity Habit Among Caregivers for Persons With AD/ADRD

**Official Title:** A Behavior Change Technique (BCT) Intervention to Develop an Hourly Activity Habit Among Caregivers for Persons Alzheimer's Disease (AD) or Alzheimer's Disease Related Dementias (ADRD)

**NCT ID:** [NCT06801912](https://clinicaltrials.gov/study/NCT06801912)

## Key Facts

- **Status:** ACTIVE_NOT_RECRUITING
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 100
- **Lead Sponsor:** Northwell Health
- **Collaborators:** National Institute on Aging (NIA)
- **Conditions:** Sedentary Behavior
- **Start Date:** 2025-03-25
- **Completion Date:** 2026-04-30
- **CT.gov Last Update:** 2026-02-27

## Brief Summary

This 12-week trial will test the efficacy of a personalized, multi-component, personalized text-message delivered behavior change technique (BCT) intervention to encourage habitual hourly physical activity among care providers of persons with Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD) via the key mechanism of behavior change (MoBC) of automaticity.

The main question it aims to answer is whether a multi-component, personalized BCT intervention to increase habitual walking of \>250 steps/hour will lead to successful development of habitual hourly walking among 50% of caregivers.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 85 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* Identify as a caregiver (formal/paid or informal/unpaid) for persons with Alzheimer's Disease or Alzheimer's Disease Related Dementias (AD/ADRD)
* Age \>=18 and \<=85
* Speak English or Spanish as primary language
* Self-report low levels of physical activity or walking

Exclusion Criteria:

* Individuals who self-report having been informed by a clinician it is medically or physically unsafe to engage in a walking intervention
* Does not own or cannot regularly access a smartphone capable of receiving text messages or accessing the internet
* Does not own or have access to an email address
* Lives outside the United States
```

## Arms

- **Behavior Change Technique Package** (EXPERIMENTAL) — This will be a 12-week, single-arm, multi-component, personalized BCT intervention. Participants will be provided with 4 BCTs daily (Goal Setting, Action Planning, Self-Monitoring, and Prompt/Cue) that have been associated with habit formation theory and development of physical activity habits in prior research.

## Interventions

- **Behavior Change Technique Package** (BEHAVIORAL) — Behavior Change Technique 1: Goal setting (Behavior) (BCT 1.1). Goal setting for behavior is defined as setting a goal for the behavior to be achieved.

Behavior Change Technique 2: Action planning (BCT 1.4). Action planning is defined as detailing the plan of where, for how long, and at what time taking medication is going to be performed.

Behavior Change Technique 3: Self-monitoring of behavior (BCT 2.3). Self-monitoring of behavior is defined as monitoring and recording behavior.

Behavior Change Technique 4: Prompts/Cues (BCT 7.1) This BCT is defined as prompt rehearsal and repetition of the behavior in the same context repeatedly, so that the context elicits the behavior.

## Primary Outcomes

- **Binary indicator of habit formation** _(time frame: Baseline to intervention period (12 weeks))_ — The primary outcome will be a binary indicator of habit formation. A null hypothesis rate of 30 percent will be used. There will be a comparison of the achieved proportion of habitual walking versus this null level, using a 1-sample binomial test with a 2-sided alpha at 5 percent. For the purposes of this current analysis, it is assumed that 50 percent of the sample will achieve habitual hourly walking following the BCT intervention to encourage habit formation. Rate of habit formation will be summarized using the observed proportion along with a 95 percent confidence interval.

## Secondary Outcomes

- **Habit formation association with changes in automaticity** _(time frame: Baseline (first 2 weeks of study) and last 2 weeks of intervention)_
- **Longitudinal association between automaticity and habitual walking over time** _(time frame: Baseline to intervention period (12 weeks))_
- **Heterogeneity of treatment effects for habit formation and on changes in automaticity** _(time frame: Baseline to intervention period (12 weeks))_

## Locations (1)

- Institute of Health System Science, New Hyde Park, New York, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.institute of health system science|new hyde park|new york|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT06801912.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT06801912*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*